The publications on this site are part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726

Informa
Skip to Page Content

Full Deal Summary

Altus Capital Partners is buying closely held spinal device maker ChoiceSpine, LP for an undisclosed sum.

Twelve-year-old ChoiceSpine offers surgical instruments used in cervical, lumbar, thoracolumbar, minimally invasive, and interbody fusion procedures. It also offers biologics such as demineralized bone matrix and bone graft putty, bone graft scaffold, regenerative tissue matrix, cervical structural and injectable amniotic fluid allografts. In early 2017 ChoiceSpine acquired Exactech’s spine products business, gaining pedicle screws, a system for posterior stabilization and fusion of the cervical and thoracic spine, cervical spacers, and an interbody fusion implant. Following that deal ChoiceSpine offered a full spinal fusion portfolio. One year ago Altus acquired cardiorespiratory-focused MGC Diagnostics.


+ Show All | – Hide All

Financials


Click a figure for comparable deals.

Overview
Equity Purchased As % 100%